First report of an AIP mutation in Nelson's syndrome successfully treated with the novel multireceptor-targeted somatostatin analogue pasireotide (SOM230)

Authors
Category Primary study
JournalExperimental and Clinical Endocrinology and Diabetes
Year 2013
This article has no abstract
Epistemonikos ID: 46fa9426ab19d9d2f6f434b6b5bec926338da650
First added on: Feb 05, 2025